ADIPOQ and non-alcoholic fatty liver: POCU1b 1.0 increased the adiponectin level, AMPK, p-AMPK, and p-ACC protein levels, as well as CPT-1 activity, and decreased FAS mRNA expression in the liver (Figure 7a and Figure 8a−d), preventing the progression of NAFL (Figure 6a−d).